Posted by Michael Wonder on 19 May 2019
Push for drug pricing transparency strikes a nerve with industry
19 May 2019 - Ahead of the World Health Assembly in Geneva, an Italian draft resolution to end secrecy around drug pricing has already ruffled feathers among some governments and industry players. Could Italy be on to something?
The resolution proposed by Italy’s Minister of Health Giulia Grillo in February urges the World Health Organization and governments to boost transparency in four areas: drug prices, R&D costs, clinical trial data, and patent information.
Arriving late in the typical resolution submission process, a frenzied review of the text revealed sharp divisions among governments. It quickly gained widespread support from many NGOs and struck a nerve with some in the pharmaceutical industry.
